| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/27/2004 | WO2004012735A3 New effector conjugates, process for their production and their pharmaceutical use |
| 05/27/2004 | WO2003099812A8 Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine |
| 05/27/2004 | WO2003088908A3 Heterocyclo inhibitors of potassium channel function |
| 05/27/2004 | WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 05/27/2004 | WO2003016276A3 3-substituted oxindole beta-3 agonists |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102626 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use cardiovascular preparations |
| 05/27/2004 | US20040102516 Crop protection agents |
| 05/27/2004 | US20040102509 Kinase inhibitors for the treatment of disease |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102500 Peroxisome proliferator activated receptor alpha agonists |
| 05/27/2004 | US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease |
| 05/27/2004 | US20040102483 Chemical compounds |
| 05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
| 05/27/2004 | US20040102466 Analgesics; antipyretics; antiinflammatory agents |
| 05/27/2004 | US20040102461 Synergistic mixture with anticancer drugs |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | US20040102449 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers |
| 05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/27/2004 | US20040102442 Central nervous system disorders; brain disorders |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102437 Prevention cytokine migration; hypotensive agents; asthma therapy |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102431 Protease inhibitors |
| 05/27/2004 | US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure |
| 05/27/2004 | US20040101535 Administering nucleoside, or prodrug thereof; viricides |
| 05/27/2004 | DE10252969A1 New 3-aminomethylene-indoline-2-(thi)one derivatives, are kinase inhibitors useful for treating proliferative diseases e.g. tumors, rheumatoid arthritis, neovascular glaucoma and arteriosclerosis |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/27/2004 | CA2505557A1 Mucin synthesis inhibitors |
| 05/27/2004 | CA2505361A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | CA2501932A1 Use of benzimidazole quinolinones for treating cancer |
| 05/26/2004 | EP1422219A1 Cyclic amine compound |
| 05/26/2004 | EP1422218A1 Antiviral agent |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1421078A1 Beta-3 adrenergic agonists |
| 05/26/2004 | EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 05/26/2004 | EP1421063A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
| 05/26/2004 | EP1420780A2 Cyclopropyl and cyclobutyl epothilone analogs |
| 05/26/2004 | EP1206474B1 Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors |
| 05/26/2004 | EP1137645B1 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group |
| 05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |
| 05/26/2004 | EP0968194B1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 05/26/2004 | CN1500087A 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 05/26/2004 | CN1500086A Aminopiperidine derivatives |
| 05/26/2004 | CN1500085A Lipid lowering biphenylcarboxamides |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1500081A Thiohydantonins and use thereof for treating diabetes |
| 05/26/2004 | CN1500080A 稠合杂环化合物 Fused heterocyclic compounds |
| 05/26/2004 | CN1500076A Sulfoxider or sulfones gralted onto polymers |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1151161C Medicine nitrate salts |
| 05/26/2004 | CN1151148C Farnesy transferase inhibitors having pyrrole structure and process for preparation thereof |
| 05/26/2004 | CN1151147C Indole derivatives as 5-HT receptor antagonist |
| 05/26/2004 | CN1151136C Fused pyridazine compound |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1151130C Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkane alcohol |
| 05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE) |
| 05/25/2004 | CA2302058C A process for preparing 5-methoxy-4-methyl-2,4-dihydro-3h-1,2,4-triazol-3-one |
| 05/25/2004 | CA2115170C Imidazolyl-alkenoic acids |
| 05/21/2004 | WO2004041811A1 3-cyano-quinoline derivatives |
| 05/21/2004 | WO2004041810A1 Compounds useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | WO2004041807A1 Novel compounds |
| 05/21/2004 | WO2004041791A1 N-aryl acetyl cyclic amine derivatives as orexin antagonists |
| 05/21/2004 | WO2004041789A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 05/21/2004 | WO2004041787A1 Process for producing quinolinecarbaldehyde |
| 05/21/2004 | WO2004041784A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 05/21/2004 | WO2004041782A1 Indoles useful in the treatment of androgen-receptor related diseases |
| 05/21/2004 | WO2004041755A2 Quinazolinone compounds as calcilytics |
| 05/21/2004 | WO2004041274A1 Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof |
| 05/21/2004 | WO2004041258A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | WO2004041211A2 INHIBITORS OF β-SECRETASE, AND THEIR USE FOR THE PREVENTION OR TREATMENT OF ALZHEIMER’S DISEASE OR MILD COGNITIVE IMPAIRMENT |
| 05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2004 | WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/21/2004 | WO2004014860A3 Fused heterocyclic compounds as peptidase inhibitors |
| 05/21/2004 | WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | WO2003086605A3 Functionalized ionic liquids, and methods of use thereof |
| 05/21/2004 | CA2507406A1 Compounds useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | CA2506772A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | CA2505239A1 Process for producing quinolinecarbaldehyde |
| 05/21/2004 | CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | CA2503716A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 05/21/2004 | CA2502302A1 Quinazolinone compounds as calcilytics |
| 05/21/2004 | CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 05/20/2004 | US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |